Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptorA E Remmers, M J Clark, A Mansour, et al.European Journal of Pharmacology|May 24, 2000
Activation of G protein by opioid receptors: role of receptor number and G-protein concentrationA E Remmers, M J Clark, A Alt, et al.AJNR. American Journal of Neuroradiology|April 12, 2014
Brain structure and function in patients after metal-on-metal hip resurfacingM J Clark, J R Prentice, N Hoggard, et al.Clinical and Experimental Pharmacology & Physiology|March 5, 1999
An action of erythromycin in the intestine that is not mediated via motilin receptorsJ B Furness, M J Clark, T Wright, et al.Oncogene|February 2, 1999
Dominant effects of the bcr-abl oncogene on Drosophila morphogenesisF J Fogerty, J L Juang, J Petersen, et al.American Journal of Public Health|September 1, 1984
Obesity prognosis: a longitudinal study of children from the age of 6 months to 9 yearsL R Shapiro, P B Crawford, M J Clark, et al.Clinical and Experimental Pharmacology & Physiology|March 19, 1999
Erythromycin derivatives ABT 229 and GM 611 act on motilin receptors in the rabbit duodenumM J Clark, T Wright, P P Bertrand, et al.Journal of Oral Surgery (American Dental Association : 1965)|May 1, 1981
Tympanometric changes after total maxillary osteotomyH M Baddour, J Watson, B J Erwin, et al.The Journal of Clinical Investigation|September 24, 1999
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cellsR G Uzzo, P Rayman, V Kolenko, et al.Genes & Development|March 1, 1995
enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding propertiesF B Gertler, A R Comer, J L Juang, et al.Pageof 9